$43,243,459
Department of Health and Human Services·National Institutes of Health
to THE JOHNS HOPKINS UNIVERSITY
biotechactive
ACTION DATE—·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI069518_075
Award description
THE MALAWI CLINICAL TRIALS UNIT
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: high
In plain English
Funds Johns Hopkins to operate a clinical trials unit in Malawi for infectious disease research and treatment studies.
Sub-sectors
clinical-trialsinfectious-diseaseglobal-health
Why this matters
Strengthens U.S. global health research capacity and generates evidence for treating diseases prevalent in sub-Saharan Africa.
U.S.–China competition angle
Establishes U.S. research presence in Africa, countering Chinese medical diplomacy and health initiatives in the region.
Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001224.
Period of performance
Start
2007-02-15
End
2027-11-30
Status
activein 565 days
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI069518_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.